A case report highlights the danger of mixing certain medications with the newest generation of weight-loss drugs.
A 62-year-old man ended up in the emergency room with hand tremors and heart palpitations six months after he began taking the weight-loss drug tirzepatide, also known as Zepbound. According to his doctors, the man’s heart predicament was likely caused by an overdose of his thyroid medication that wasn’t adjusted properly following his rapid weight loss from tirzepatide.medication, a class of drugs that mimics gut and brain hormones important to regulating hunger and metabolism.
Unfortunately, the dosage of levothyroxine needed to mimic a healthy thyroid can be affected by lots of things, including body weight. And the man’s weight loss meant that he was now taking too much levothyroxine. His atrial fibrillation and resulting symptoms were officially determined to be caused by an overflow of thyroid hormones in “the context of rapid weight loss from tirzepatide.” Thankfully, he received immediate treatment for his condition in the emergency department.
Other research has generally found that incretin drugs may have even more health benefits than currently thought. A study this Februarythat it could be used to treat sleep apnea. But the man’s doctors say this case should provide a “teachable moment”—the lesson being that every drug, no matter how useful, can have risks that should be proactively monitored by clinicians.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Micah Parsons reveals weight loss; down to college playing weightDallas Cowboys superstar Micah Parsons is taking on a versatile role in new defensive coordinator Mike Zimmer's system, and he'll be lighter on his feet.
Read more »
Ozempic, Weight Loss Drugs, and Vision Loss: What to Know About Recent StudyYou may have heard of type 1 and type 2, but there are many more types of diabetes you should know about. Here are six types, from gestational to monogenic.
Read more »
Yes, there are safety concerns with buying knockoff weight-loss drugsA group of wild horse advocates are hoping to find homes for mustangs rounded up in Wyoming earlier this year.
Read more »
Study: Weight loss more likely with certain drugs than othersPatients on Mounjaro were both more likely to lose weight and saw larger reductions in body weight than patients on Ozempic.
Read more »
Popular weight-loss and diabetes medications linked to lower risk of some cancers, study findsThe new findings that link GLP-1 treatment to reduced risk of some cancers 'compare favorably' with similar effects linked to intensive lifestyle intervention and metabolic-bariatric surgery that have been found in other trials, the study authors wrote.
Read more »
Mounjaro leads to significantly more weight loss than Ozempic, study suggestsWith more people using drugs like Ozempic and Wegovy for weight loss, food companies are paying close attention and trying to adapt to changing eating habits.
Read more »